April 5, 2018 / 12:18 PM / in 3 months

BRIEF-On Target Laboratories Says First Patient Treated In Key Ovarian Cancer Trial

April 5 (Reuters) - On Target Laboratories:

* FIRST PATIENT TREATED IN PIVOTAL PHASE 3 TRIAL TO EVALUATE OTL38 IN THE DETECTION OF OVARIAN CANCER Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below